ACETYLSALICYLIC ACID 325MG TAB TABLET Canada - English - Health Canada

acetylsalicylic acid 325mg tab tablet

drug trading company ltd. - acetylsalicylic acid - tablet - 325mg - acetylsalicylic acid 325mg - salicylates

ACETYLSALICYLIC ACID 325MG TABLETS USP Canada - English - Health Canada

acetylsalicylic acid 325mg tablets usp

prodemdis enr. - acetylsalicylic acid - tablet - 325mg - acetylsalicylic acid 325mg - salicylates

ACETYLSALICYLIC ACID 325MG TABLETS USP Canada - English - Health Canada

acetylsalicylic acid 325mg tablets usp

cellchem pharmaceuticals inc. - acetylsalicylic acid - tablet - 325mg - acetylsalicylic acid 325mg - salicylates

Clopidogrel/Acetylsalicylic acid Teva European Union - English - EMA (European Medicines Agency)

clopidogrel/acetylsalicylic acid teva

teva pharma b.v. - clopidogrel, acetylsalicylic acid - acute coronary syndrome; myocardial infarction - combinations - clopidogrel/acetylsalicylic acid teva is indicated for the prevention of atherothrombotic events in adult patients already taking both clopidogrel and acetylsalicylic acid (asa). clopidogrel/acetylsalicylic acid teva is a fixed‑dose combination medicinal product for continuation of therapy in:non‑st segment elevation acute coronary syndrome (unstable angina or non‑q‑wave myocardial infarction) including patients undergoing a stent placement following percutaneous coronary interventionst segment elevation acute myocardial infarction in medically treated patients eligible for thrombolytic therapy

Clopidogrel / Acetylsalicylic acid Mylan European Union - English - EMA (European Medicines Agency)

clopidogrel / acetylsalicylic acid mylan

mylan pharmaceuticals limited - acetylsalicylic acid, clopidogrel hydrogen sulfate - acute coronary syndrome; myocardial infarction - antithrombotic agents - clopidogrel/acetylsalicylic acid mylan is indicated for the secondary prevention of atherothrombotic events in adult patients already taking both clopidogrel and acetylsalicylic acid (asa).clopidogrel/acetylsalicylic acid mylan is a fixed-dose combination medicinal product for continuation of therapy in:non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction) including patients undergoing a stent placement following percutaneous coronary interventionst segment elevation acute myocardial infarction in medically treated patients eligible for thrombolytic therapy

ACETYLSALICYLIC ACID TAB 325MG TABLET Canada - English - Health Canada

acetylsalicylic acid tab 325mg tablet

pharmel inc - acetylsalicylic acid - tablet - 325mg - acetylsalicylic acid 325mg - salicylates

ACETYLSALICYLIC ACID A.S.A. TABLETS 325MG Canada - English - Health Canada

acetylsalicylic acid a.s.a. tablets 325mg

westcan pharmaceuticals ltd. - acetylsalicylic acid - tablet - 325mg - acetylsalicylic acid 325mg - salicylates

ACETYLSALICYLIC ACID TAB 325MG BP TABLET Canada - English - Health Canada

acetylsalicylic acid tab 325mg bp tablet

wes pak products ltd. - acetylsalicylic acid - tablet - 325mg - acetylsalicylic acid 325mg - salicylates

ACETYLSALICYLIC ACID STOMACH PROTECTION 325MG TABLETS Canada - English - Health Canada

acetylsalicylic acid stomach protection 325mg tablets

cellchem pharmaceuticals inc. - acetylsalicylic acid - tablet - 325mg - acetylsalicylic acid 325mg - salicylates

Clopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) European Union - English - EMA (European Medicines Agency)

clopidogrel/acetylsalicylic acid zentiva (previously duocover)

sanofi-aventis groupe - clopidogrel, acetylsalicylic acid - acute coronary syndrome; myocardial infarction - antithrombotic agents - acute coronary syndromemyocardial infarction